This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Addressing Suboptimal Therapeutic Response Among Patients with MS

Addressing Suboptimal Therapeutic Response Among Patients with MS



Time to Complete

1 hour


December 28, 2017


February 28, 2019
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider

Jointly provided by Postgraduate Institute for Medicine and Enquiring Minds

Commercial Supporter

Supported by an independent educational grant from Sanofi Genzyme

Program Description

Make real-world decisions and customize treatment plans in this dynamic case-based activity.

Intended Audience

This activity is intended for physicians engaged in the care of patients with multiple sclerosis (MS).

Educational Objectives

Upon completion of the activity, participants should be better able to:

  • Evaluate and appropriately apply the latest clinical evidence and recommendations when safely and effectively integrating current and emerging therapies into treatment plans for MS
  • Employ patient-centered approaches when determining barriers to optimal therapeutic response and strategies to overcome them

Conflict Of Interest Disclosure Policy

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.


Andrew J. Solomon, MD
Associate Professor of Neurological Sciences
Division Chief, Multiple Sclerosis
University of Vermont College of Medicine
Burlington, VT

Dr. Solomon discloses the following:
Consulting Fees: Genentech, EMD Serono, Teva, Biogen

Stephen Krieger, MD
Associate Professor of Neurology
Director, Neurology Residency Program
Icahn School of Medicine at Mount Sinai
New York, NY

Dr. Krieger discloses the following:
Consulting Fees: Acorda, Bayer, Biogen, EMD Serono, Genentech, Genzyme, Mallinckrodt, Novartis, Teva
Contracted Research: MedDat, TG Therapeutics
Fees from Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: Biogen and Genentech

Accredited Provider Disclosures

Planners and Managers
The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN, and Jan Schultz, RN, MSN, CHCP, have nothing to disclose. The Enquiring Minds, LLC medical writers, Karen Chiu and Emma Nichols, PhD, have nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

In support of improving patient care, these activities have been planned and implemented by the Postgraduate Institute for Medicine and Enquiring Minds. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


In order to receive credit, participants must complete the program evaluation. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact

Media Format


Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue